Company Directory - IDEXX Laboratories, Inc.
Company Details - IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
WebsiteWestbrook, United States
IDEXX Laboratories, Inc. is a global leader in veterinary diagnostics and laboratory services. The company offers innovative diagnostic and information technology solutions that empower veterinarians, livestock and poultry producers, and testing laboratories worldwide to improve animal health and well‐being.
CCI Score
CCI Score: IDEXX Laboratories, Inc.
-0.01
Latest Event
Court Decision Highlights Anticompetitive Practices by IDEXX Laboratories
A U.S. District Court decision in the case Yuen v. IDEXX Labs. detailed allegations that IDEXX engaged in anticompetitive behavior by enforcing restrictive, long-term exclusive contracts with veterinary practices. These practices, including steep penalty provisions that lock in customers, have been accused of contributing to inflated prices and a monopolistic market structure in veterinary diagnostic products.
Take Action
So what can you do? It's time to make tough choices. Where will you cast your vote?
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
BYSTANDER
IDEXX Laboratories, Inc. is currently rated as a Bystander.
Latest Events
- JAN082024
A U.S. District Court decision in the case Yuen v. IDEXX Labs. detailed allegations that IDEXX engaged in anticompetitive behavior by enforcing restrictive, long-term exclusive contracts with veterinary practices. These practices, including steep penalty provisions that lock in customers, have been accused of contributing to inflated prices and a monopolistic market structure in veterinary diagnostic products.
-60
Business Practices and Ethical Responsibility
March 29
The court documents detail IDEXX's use of exclusive six‐year contracts with steep penalty provisions that lock in veterinary practices, effectively preventing competition and leading to overpricing. Such practices undermine ethical business responsibility by prioritizing monopoly power over fair market competition.
-40
Economic and Structural Influence
March 29
The allegations reveal that IDEXX’s dominance in the veterinary diagnostic market is bolstered by exclusionary practices that create high barriers to entry, consolidating monopoly power and negatively impacting market dynamics and consumer welfare.
- JAN012024
The OpenSecrets profile indicates that during the 2024 election cycle, IDEXX Laboratories contributed $50,882 with no reported lobbying or outside spending, reflecting a minimal and non-expansive political engagement that avoids fueling authoritarian influences.
+30
Political Contributions and Lobbying Efforts
March 29
IDEXX Laboratories’ low-level political contributions and complete abstention from lobbying and outside spending during the 2024 election cycle suggest a minimal role in political influence. This limited political engagement is seen as a positive indicator from an anti-fascist perspective, as it reduces the risk of supporting authoritarian agendas.
- OCT012023
IDEXX Laboratories, Inc. published its corporate responsibility statement emphasizing a commitment to ethical practices, innovation in veterinary diagnostics, diversity, equity, and inclusion, as well as sustainability and positive community impact.
+70
Labor Relations and Human Rights Practices
October 1
The statement highlights IDEXX's pledge to build a collaborative and ethical corporate culture with strong commitments to diversity, equity, and inclusion, as well as community and environmental well-being. This positive emphasis on human rights and responsible business practices aligns with progressive, anti-authoritarian principles.
- MAR312023
IDEXX Laboratories has launched a human rights risk assessment focused on a segment of its supply chain. The goal of the assessment, expected to be completed during 2023, is to identify and manage associated human rights risks, reinforcing ethical sourcing and strengthening labor practices.
+70
Supply Chain Ethics
March 29
By instituting a human rights risk assessment within its supply chain, IDEXX is taking a proactive step to ensure ethical sourcing and the protection of labor rights, which aligns with anti-authoritarian, progressive corporate practices. This move mitigates potential complicity in human rights abuses and promotes transparency and accountability within its business practices.
- DEC132022
A class-action lawsuit filed by 22 pet owners alleges that IDEXX Laboratories used long-term, restrictive contracts with steep purchasing and disloyalty penalty provisions to lock in veterinarians, suppress competitive pricing, and dominate the diagnostic test market.
-80
Business Practices and Ethical Responsibility
March 29
IDEXX is accused of engaging in unethical business practices by enforcing long-term exclusive agreements with veterinarians that include steep purchasing requirements and harsh penalty clauses. These practices are seen as predatory and serve to eliminate competition, thereby harming consumer interests and market fairness.
Pet owners sue IDEXX over 'anticompetitive scheme to sell diagnostic tests'
-70
Economic and Structural Influence
March 29
The suit highlights IDEXX’s dominant market position, holding over 70% of U.S. diagnostic test sales, which, coupled with the exclusive contractual arrangements, represents a significant economic and structural influence that stifles competition and reinforces monopoly power.
Pet owners sue IDEXX over 'anticompetitive scheme to sell diagnostic tests'
- JUL272022
A proposed class action lawsuit alleges that IDEXX Laboratories used long-term exclusive contracts with veterinary practices, including automatic renewals and steep penalty provisions, to foreclose competition and inflate prices for diagnostic tests, thereby damaging market fairness and consumer interests.
-90
Business Practices and Ethical Responsibility
March 29
The lawsuit details how IDEXX Laboratories employs unethical business practices by locking veterinary practices into long-term, exclusive contracts with severe financial penalties. This anti-competitive behavior restricts market access for competitors and ultimately harms consumers through inflated prices, aligning with systems that undermine fair labor and market practices.
-80
Economic and Structural Influence
March 29
The complaint contends that IDEXX’s direct sales strategy and exclusive contracts have restructured the market dynamics in its favor. By effectively creating a monopolistic environment, these practices reduce competition and contribute to artificially high prices, reflecting undue economic and structural influence.
- MAR012021
IDEXX Laboratories, Inc. released an updated policy outlining its approach to political contributions and public policy engagement effective March 1, 2021. The policy emphasizes that the company will not use corporate funds to support or oppose political candidates or incumbents and details a pre-clearance process for any political activities, ensuring compliance with relevant laws, ethical standards, and the company’s commitment to good corporate citizenship.
+40
Political Contributions and Lobbying Efforts
March 29
The policy clearly articulates that IDEXX Laboratories will refrain from using corporate funds for direct political support, thereby reducing the risk of corporate influence on partisan processes. By instituting a pre-clearance process for political expenditures and ensuring oversight by its Board of Directors and Government Affairs team, IDEXX demonstrates a commitment to ethical political engagement. This approach minimizes the likelihood of the company inadvertently supporting authoritarian or far-right agendas, which is viewed positively from an anti-fascist perspective.
PDF Policy on Political Contributions and Public Policy Engagement - IDEXX
Alternatives
Washington, D.C., United States
21.28
Suresnes, France
-76.61
Corporation
5.76
Corporation
0.00
San Diego, United States
-30.29
Gerlingen, Germany
-35.73
Corporation
0.00
Corporation
0.00
Corporation
-26.59
Corporation
-29.48
Industries
- 325413
- In-Vitro Diagnostic Substance Manufacturing
- 334516
- Analytical Laboratory Instrument Manufacturing
- 541714
- Research and Development in Biotechnology (except Nanobiotechnology)